update
MilliporeSigma has signed an excipient distribution deal with PCAS
MilliporeSigma will distribute range of lactic acid sustained release excipients under a deal with French developer PCAS.
Archives for July 17, 2016
World bank will loan B. Braun $33m for Indonesia injectables plant
The World Bank has confirmed it will loan B. Braun $33m (€30m) to help pay for a manufacturing facility in Indonesia.
GE Healthcare eyeing more cell and gene therapy production tech supplier takeovers
GE Healthcare has hinted that more gene and cell therapy acquisitions will follow its takeover of the Biosafe Group.
World Courier discusses how healthcare, supply chain and public safety are inextricably linked
Paid for and content provided by World Courier
In globalising the pharmaceutical industry oversight and control has increasingly become a challenge in managing product quality, consumer safety and organisational risk.
CSafe opens new service center in Puerto Rico
The cold chain solution company, CSafe, has opened a new San Juan-based service center in conjunction with the launch of its new company, CSafe Puerto Rico LLC.
NCI: global initiative to create 1,000 cancer cell models
A newly-launched international project seeks to develop a new bank of cancer cell culture models for the research community.
Parexel CFO resigns; may be heading to Germany-based firm
Parexel has confirmed that CFO Ingo Bank has resigned a little over three years after joining the US contract research organisation (CFO).
MonoSol Rx licenses film tech to Kuraray-owned namesake for non-pharma uses
MonoSol Rx licenses delivery film tech to MonoSol LLC for non-pharma uses.
Ziopharm investigating death in Ph I trial of brain cancer gene therapy
Ziopharm Oncology has started investigating a death that occured during a Ph I trial of its candidate brain cancer gene therapy, Ad-RTS-hIL-12.
Enrolling patients and keeping them: electronic patient recruitment companies collaborate
eClinicalHealth and Clinerion have announced a collaboration under which the companies will offer their complementary technologies jointly to hospitals and sponsor companies/CROs.